The PML-RARα fusion oncoprotein, which is the product of this chromosomal aberrancy, function as a transcriptional repressor in APL cells, leading to aberrant expression of genes involved in blood cell differentiation [115,116,117]. The gene discussed is RARA; the disease is acute promyelocytic leukemia.